Capsugel has manufactured Phase II clinical trial supplies for a dry powder inhalation (DPI) formulation that delivers biotherapeutics to the lung using a combination of formulation, particle engineering and spray-drying processing methods. The supplies were manufactured by Bend Research, part of Capsugel’s Dosage Form Solutions business unit. The inhaled dry-powder biotherapeutic is the first inhalation delivery therapy to be manufactured to Phase II scale at the company’s clinical trial manufa...